Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Swaroop S. Sonone | Medicine and Health Sciences | Best Faculty Award

Published on by Forensic Scientist

Mr. Swaroop S. Sonone | Medicine and Health Sciences | Best Faculty Award

School of Forensic Sciences, JSPM University, Pune | India

Mr. Swaroop S. Sonone, Assistant Professor at the School of Behavioural and Forensic Sciences, Jayawant Shikshan Prasarak Mandal (JSPM) University, Pune, India, is a distinguished academic and researcher specializing in Digital and Cyber Forensics, Forensic Ballistics, and Cyber Psychology. He holds an M.Sc. in Forensic Science (Digital & Cyber Forensics) and a B.Sc. in Forensic Science from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, along with a Diploma in Photography. He has qualified multiple national eligibility tests, including UGC-NET (three times) and MH-SET (SPPU, 2021), showcasing his academic competence and commitment to higher education. His research credentials, as indexed in Scopus (Author ID: 57219960845; ORCID: 0000-0002-3358-348X), include 24 publications, 670 citations, and an h-index of 5, reflecting his consistent scholarly contribution and scientific impact. Mr. Sonone has demonstrated exemplary academic leadership as Programme Coordinator, IQAC Coordinator, and Editor of the International Journal of Forensic Sciences (IJFSC). His notable publications, such as Water Contamination by Heavy Metals (2020) and Unveiling the Power of Nanoparticles for Latent Fingerprints (2024), highlight his interdisciplinary expertise bridging forensic and environmental sciences. Recognized for his excellence in teaching and research, he received the Young Forensic Faculty Award (NAEF-2025) by ThinkSakshya. Beyond academia, he actively engages in public science communication through national media, fostering forensic awareness. With his intellectual rigor, innovation, and leadership, Mr. Swaroop S. Sonone continues to advance forensic science education and research in India, exemplifying professional excellence and academic integrity.

Profile: Scopus | ORCID | Google Scholar | ResearchGate | LinkedIn | Staff Page

Featured Publications

  • Sonone, S. S., Jadhav, S., Sankhla, M. S., & Kumar, R. (2020). Water contamination by heavy metals and their toxic effect on aquaculture and human health through food chain. Letters in Applied NanoBioScience, 10(2), 2148–2166. Cited by 562.

  • Gulia, S., Rohilla, R. K., Sankhla, M. S., Kumar, R., & Sonone, S. S. (2020). Impact of pesticide toxicity in aquatic environment. Biointerface Research in Applied Chemistry, 11(3), 10131–10140. Cited by 166.

  • Verma, R. K., Sankhla, M. S., Rathod, N. V., Sonone, S. S., Parihar, K., & Singh, G. K. (2022). Eradication of fatal textile industrial dyes by wastewater treatment. Biointerface Research in Applied Chemistry, 12(1), 567–587. Cited by 74.

  • Mohan, H., Rajput, S. S., Jadhav, E. B., Sankhla, M. S., Sonone, S. S., Jadhav, S., et al. (2021). Ecotoxicity, occurrence, and removal of pharmaceuticals and illicit drugs from aquatic systems. Biointerface Research in Applied Chemistry, 11(5), 12530–12546. Cited by 65.

  • Singhal, M., Jadhav, S., Sonone, S. S., Sankhla, M. S., & Kumar, R. (2021). Microalgae-based sustainable bioremediation of water contaminated by pesticides. Biointerface Research in Applied Chemistry, 12, 149–169. Cited by 54.

Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Mr. Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Beijing Stomatological Hospital Affiliated to Capital Medical University | China

Hanchen Zhou, a graduate student at Beijing Stomatological Hospital, Capital Medical University, is an emerging researcher specializing in Oral and Maxillofacial-Head and Neck Oncology, with a primary focus on oral squamous cell carcinoma. He has already distinguished himself by publishing four SCI-indexed research papers that contribute valuable insights into the molecular mechanisms, clinical behavior, and potential treatment strategies for this aggressive malignancy. These publications, cited internationally, reflect his growing influence in oncology research and his ability to translate clinical challenges into innovative scientific solutions. Zhou is actively engaged in funded research projects, including the Innovation Foundation and the Clinical Research Incubation Project of Beijing Stomatological Hospital, demonstrating his capacity to design and execute impactful investigations. A member of the Chinese Stomatological Association, he actively participates in academic collaboration and professional development, strengthening his role within the wider scientific community. Despite being in the early stages of his career, Zhou has already showcased a strong commitment to advancing cancer research, particularly in bridging experimental findings with clinical applications. His work not only enhances the understanding of oral squamous cell carcinoma but also paves the way for improved diagnostic and therapeutic approaches. By integrating scientific rigor with a clear vision for innovation, he exemplifies the qualities of a promising researcher poised for long-term impact.

Profile: Scopus | ResearchGate

Featured Publications

  • Yu, H., Li, B., Huang, Y., & Zhang, X. (2025). Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: A retrospective cohort analysis. Frontiers in Oncology, 15, Article 1667226. https://doi.org/10.3389/fonc.2025.1667226

  • Zhou, H., Luo, C., Xu, Q., & Wang, C. (2025). Machine learning approach to predict surgical site infection in head and neck squamous cell carcinoma patients after free flap reconstruction. Journal of Cranio-Maxillofacial Surgery. Advance online publication. https://doi.org/10.1016/j.jcms.2025.09.010

  • Cheng, A., Wei, K., Xu, Q., & Wang, C. (2025). The comparison of the prognostic value of different inflammation-related indicators in patients with oral squamous cell carcinoma. Frontiers in Genetics, 16, Article 1652603. https://doi.org/10.3389/fgene.2025.1652603

  • Li, B., Zhao, Z., Huang, Y., & Zhou, H. (2025). The application of adjuvant radiotherapy in pN1 OSCC patients without adverse pathologic features. Oral Diseases, 31(1), e15336. https://doi.org/10.1111/odi.15336

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Zhiliang Xu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Prof. Zhiliang Xu | Medicine and Health Sciences | Best Researcher Award

Wannan Medical College | China

Prof. Zhiliang Xu, affiliated with Wannan Medical College, Wuhu, China, is a distinguished molecular biologist and epigenetics researcher whose work focuses on histone ubiquitination, chromatin remodeling, and their implications in neurological disorders, cancer, gametogenesis, and cellular reprogramming. He earned his Ph.D. from the State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences in 2017. According to Scopus, Prof. Zhiliang Xu has authored 11 publications, which have been cited 34 times, and he holds an h-index of 4, demonstrating the impact of his research in the scientific community. His seminal studies elucidated the role of H2B ubiquitination in chromatin relaxation during meiosis and cellular reprogramming, published in journals such as Nucleic Acids Research (2016), Cell Proliferation (2021), and Reproduction (2017). His recent work on neuronal repair, gut-liver axis regulation in diabetes, and genomic approaches to thalassemia has been featured in FASEB Journal (2025), Annals of Hematology (2025), and Neuroscience Letters (2025). Prof. Zhiliang Xu leads multiple high-impact national and provincial research projects, serves as a peer reviewer for journals including Scientific Reports and Neurochemical Research, and evaluates theses for graduate and doctoral candidates. Recognized with the 2021 National Maternal and Child Health Science and Technology Award (First Prize), the 2022 Guangzhou High-level Talent Award, and the 2024 Outstanding Young Talent honor in Anhui Province, Prof. Zhiliang Xu continues to advance fundamental understanding of chromatin biology and epigenetic regulation, exemplifying excellence, mentorship, and translational scientific impact, making him an outstanding candidate for the Best Researcher Award.

Profile: Scopus | ORCID

Featured Publications

1. Shi, L., Yan, X., Xia, Y., Zhao, Y., Zhu, X., Li, Q., & Xu, Z. (2025). Beyond transfusions and transplants: Genomic innovations rewriting the narrative of thalassemia. Annals of Hematology.

2. Zhang, Y., Wang, J., Huang, S., Liu, M., Zhao, Y., Xu, Z., & Zhu, X. (2025). Electroacupuncture preconditioning alleviates cortical neuronal injury in cerebral ischemia-reperfusion by rebalancing HES1 and NF-κB expression. Neuroreport.

3. Yan, X., Shi, L., Zhu, X., Zhao, J., Zhao, Y., Luo, J., Li, Q., & Xu, Z. (2025). From microbial homeostasis to systemic pathogenesis: A narrative review on gut flora’s role in neuropsychiatric, metabolic, and cancer disorders. Journal of Inflammation Research.

4. Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025). Neurodegenerative diseases and neuroinflammation-induced apoptosis. Open Life Sciences.

5. Li, Q., Zhang, L., Sun, Y., Du, Z., Xu, S., Wang, X., Wei, S., Tao, Y., Li, B., Jiang, J., Di, G., Huang, Y., & Xu, Z. (2025). p53 modulates the gut-liver axis via PI3K/AKT/Wnt signaling pathways in type 2 diabetes. FASEB Journal.

6. Li, Q., Yan, X., Zhao, Y., Xu, Z., & Zhu, X. (2025). Paeonol mitigates chronic stress-induced amygdalar neuronal damage through glycogen synthase kinase-3β/calcineurin axis regulation of synaptic plasticity. Neuroreport.

7. Zhu, X., Zhang, Y., Yan, X., Zhao, Y., Shi, L., Sun, Z., Meng, K., Zong, Y., Li, Q., & Xu, Z. (2025). Paeonol facilitates the repair of neuronal damage in the mPFC caused by chronic stress via the Rho GTPases-cofilin1 signaling pathway. Neuroscience Letters, 138329.

Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

University Hospital Basel | Switzerland

Dr. Andrej Sirek is a dedicated Pathology Resident at the University Hospital Basel, Institute of Medical Genetics and Pathology, where he is actively shaping his career at the intersection of clinical diagnostics and medical research. With his educational foundation built in leading European institutions, Dr. Andrej Sirek has developed a strong grounding in medical genetics, histopathology, and laboratory sciences, which now supports his dual role as both clinician and researcher. His residency provides him with exposure to complex pathology cases while also allowing him to engage in research that seeks to bridge genetic profiling and diagnostic pathology, with the long-term aim of contributing to precision medicine and early disease detection. Currently, he has completed one research project and is progressing with another, both expected to yield indexed publications in the near future. Despite being at an early stage of his academic career, his commitment to innovation in pathology has already been recognized with a nomination for the Best Researcher Award. He maintains active membership in several professional organizations, including SGPATH, ÖGPATH, SGZ, and ESP, which strengthens his global collaborations and engagement with the wider pathology community. While he has yet to publish peer-reviewed articles, his ongoing research demonstrates his potential to make impactful contributions to the field. His academic and professional journey underscores the promise of a new generation of clinician-scientists who integrate advanced diagnostic techniques with research innovation to improve patient care. Dr. Andrej Sirek’s trajectory highlights his dedication, scholarly potential, and commitment to excellence in pathology and medical genetics.

Profile: ORCID

Featured Publications

Dr. Andrej Sirek has contributed to impactful research in pathology, focusing on diagnostic innovations, tumor biology, and clinicopathological correlations. Key recent publications include:

Sirek, A., Hench, I. B., Hench, J., Alborelli, I., Gross, M. W., Jakscha, J., Schaller, P., Nagel, G., Baumhoer, D., & Tzankov, A. (2025). Recurrent clonal radiotherapy-associated fibroepithelial polyp of the pharynx: Do low grade radiogenic stromal tumours exist? Case report.

Sobottka, B., Vetter, V., Banaei-Esfahani, A., Nowak, M., Lorch, A., Sirek, A., Mertz, K. D., Brunelli, M., Berthold, D., de Leval, L., et al. (2024). Immune phenotype-genotype associations in primary clear cell renal cell carcinoma and matched metastatic tissue.

Begum Ertan | Medicine and Health Sciences | Young Researcher Award

Published on by Forensic Scientist

Dr. Begum Ertan | Medicine and Health Sciences | Young Researcher Award

Sandikli State Hospital | Turkey

Dr. Begum Ertan is an accomplished medical doctor and specialist in Gynecology and Obstetrics, serving at Afyonkarahisar Sandikli State Hospital. She is recognized for her dedication to advancing women’s reproductive health, blending clinical expertise with a strong commitment to academic research. Her work spans adenomyosis diagnosis, infertility treatment, IVF success prediction, and gynecologic oncology. Actively engaged in professional societies, she is a core group member of the Turkish Endometriosis and Adenomyosis Society. Dr. Ertan combines patient-centered care with cutting-edge scientific approaches, striving to improve diagnostic accuracy, treatment outcomes, and overall quality of life for women.

Professional Profile

Scopus

Education

Dr. Ertan completed her medical degree at Celal Bayar University, Faculty of Medicine, where she laid a strong foundation in clinical sciences and patient care. She then specialized in Obstetrics and Gynecology at Dokuz Eylül University, Faculty of Medicine, developing advanced skills in reproductive medicine, maternal-fetal health, and minimally invasive surgical techniques. Her education was enriched by exposure to diverse clinical cases and participation in academic projects, fostering her dual role as a skilled clinician and committed researcher.

Experience

With extensive experience as a Gynecology and Obstetrics Specialist, Dr. Ertan has managed complex cases involving high-risk pregnancies, reproductive endocrinology, and gynecologic surgery. She has contributed to multidisciplinary medical teams, enhancing patient outcomes through evidence-based approaches. Her professional activities include presenting original research at leading national and international conferences, authoring peer-reviewed publications, and writing academic book chapters on endometriosis, infertility, and hormonal therapies. In addition to her hospital duties, she actively participates in community health initiatives, delivering educational seminars on women’s health and hygiene.

Research Interests

Dr. Ertan’s research is driven by a commitment to improving women’s reproductive health through innovative diagnostic and therapeutic methods. She is particularly interested in adenomyosis detection using advanced imaging modalities, identifying predictive factors for IVF success, evaluating the impact of early pregnancy findings on pregnancy outcomes, and exploring rare gynecologic pathologies. Her studies also address the role of hysteroscopic evaluation in abnormal uterine bleeding and the relationship between ovarian conditions and fertility potential. By integrating clinical insight with research innovation, she aims to bridge the gap between academic findings and real-world patient care.

Awards

Dr. Ertan’s professional trajectory reflects the qualities sought in the Young Researcher Award  innovation, dedication, and measurable contributions to the field. Her growing portfolio of scientific publications, her active participation in professional societies, and her involvement in public health education underscore her status as a promising and impactful early-career researcher in obstetrics and gynecology.

Publications

  • Title: Prediction of adenomyosis according to revised definitions of morphological uterus sonographic assessment features
    Journal: Frontiers in Medicine
    Published on: August 2024

  • Title: Comparison of Patients with Adenomyosis Detected in Hysterectomy Material and Patients with Other Benign Pathologies: Retrospective Study
    Journal: Turkish Journal of Reproductive Medicine and Surgery
    Published on: 2024

  • Title: Impact of ovarian cysts observed on the initial day of ovulation induction on the success rates in IVF cycles
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Correlation of adenomyosis risk factors with pathologic diagnosis
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Pregnancy Loss Prediction Based on Early First Trimester Ultrasound
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Ovarian hilus cell hyperplasia and sertoli-leydig cell tumor in a patient with postmenopausal virilization: a rare case report
    Journal: Aegean Journal of Obstetrics and Gynecology
    Published on: December 2021

Conclusion

Dr. Begum Ertan embodies the profile of an emerging leader in reproductive medicine. Her clinical expertise, research productivity, and academic contributions have already made a significant impact on the field. Through her continued work in advanced gynecologic diagnostics, fertility treatment, and women’s health advocacy, she demonstrates exceptional promise as a young researcher. Her commitment to bridging scientific innovation with practical healthcare solutions makes her a strong and deserving candidate for the Young Researcher Award.

Chunmei Qin | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Chunmei Qin | Medicine and Health Sciences | Best Researcher Award

Luzhou People’s Hospital | China

Dr. Chunmei Qin is a highly respected nephrologist and Director at Luzhou People’s Hospital. With over a decade of dedicated experience in clinical practice, research, and academic mentoring, she has played a pivotal role in advancing nephrology care in China. Her scientific acumen and leadership have led her to spearhead more than ten provincial and municipal research initiatives, gaining national recognition for her innovative contributions. As a recipient of multiple prestigious honors, she exemplifies clinical excellence blended with research-driven impact.

Author Profile👤

Scopus

Strengths for the Awards✨

Dr. Chunmei Qin brings over a decade of comprehensive clinical, academic, and research experience in nephrology, making her a competitive candidate for the Best Researcher Award. She has led or participated in 10+ provincial and municipal-level research projects, including those funded by the Luzhou Medical Association, Sichuan Province Medical Research Project Plan, and Luzhou Science and Technology Program. Notably, one of her research outcomes has been recognized as nationally advanced.

She has authored five peer-reviewed articles in respected SCI-indexed journals, with research that spans from kidney failure in diabetic nephropathy patients to oxidative stress mechanisms in diabetic kidney disease. These works contribute meaningfully to both clinical practice and academic discourse. Additionally, she has received multiple accolades, including:

  • Outstanding Young Paper Award by the Sichuan Medical Association.

  • Outstanding Contribution Award by the Municipal Health Commission.

Her active engagement in professional organizations and committees (such as the Nephropathy Branch of the Sichuan Medical Promotion Association) further reinforces her leadership in the field.

🎓 Education

Dr. Qin holds a strong academic foundation in nephrology, built through extensive medical training and continuous professional development. Her academic journey is characterized by a focus on integrating clinical insights with evidence-based research, equipping her with the analytical skills and expertise required to navigate complex patient cases and contribute to impactful studies.

🏥 Experience

Currently serving as Director at Luzhou People’s Hospital, Dr. Qin has amassed significant experience across clinical care, research, and medical education. Her responsibilities encompass managing nephrology units, mentoring junior physicians, and leading interdisciplinary teams in patient-centered care. Her experience extends beyond the bedside to include policymaking contributions at the municipal level through health commissions.

🔬 Research Interests On Medicine and Health Sciences

Dr. Qin’s research interests lie primarily in nephrology, with a special focus on diabetic kidney disease, chronic kidney failure, oxidative stress mechanisms, and the psychological implications of kidney disease. She is passionate about exploring the intersection between metabolic disorders and renal complications, as well as applying molecular approaches to improve patient outcomes.

🏆 Awards

Dr. Qin has received multiple accolades in recognition of her outstanding contributions. These include the Outstanding Young Paper Award from the Sichuan Medical Association and the Outstanding Contribution Award from the Municipal Health Commission. Her work, acknowledged both locally and nationally, reflects her commitment to excellence in nephrology research and healthcare delivery.

📄 Publications

Dr. Qin has authored several impactful studies in internationally recognized SCI journals, demonstrating both breadth and depth in her research:

  1. Qin, C., Wu, Y., Zou, Y., et al. Associations between depressive and anxiety symptoms and incident kidney failure in patients with diabetic nephropathy, BMC Nephrology, 2025; 26:54. Cited by multiple nephrology scholars for its clinical relevance.

  2. Qin, C., Wang, Y., Zhao, L., et al. Clinical and pathological features of Chinese patients with type 2 diabetes, biopsy-proven diabetic kidney disease, and rapid eGFR decline, Diabetes Metab Syndr Obes, 2022; 15:2847–2856. Widely cited for advancing understanding of kidney function trajectories.

  3. Qin, C., Yin, D., Liu, F., et al. Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy: a case report, BMC Nephrology, 2023; 24(1):143. Referenced in case studies on rare renal pathologies.

  4. Zhang, R., Qin, C., Zhang, J., et al. DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/P66shc pathway in diabetic kidney disease, FASEB Journal, 2024; 38(6):e23564. Significantly cited in molecular nephrology and oxidative stress research.

  5. Qin, C., Li, G., Yuan, Y., et al. Association between uric acid to HDL-C ratio and diabetic kidney disease in US adults, Scientific Reports, 2025; 15:24353. Cited for its epidemiological insights on metabolic markers.

Arman Soltani Moghadam | Medicine | Best Researcher Award

Published on by Forensic Scientist

Dr. Arman Soltani Moghadam | Medicine | Best Researcher Award

Tehran Herat Center | Iran

Dr. Arman Soltani Moghadam is a dedicated medical doctor and cardiovascular researcher based in Tehran, Iran. With a strong foundation in clinical medicine and an exceptional academic record, he has significantly contributed to cardiology through both clinical practice and extensive research collaborations internationally. Known for his precision in diagnostics and passion for scientific inquiry, he serves as a General Practitioner while actively engaging in cutting-edge cardiovascular research with institutions such as Tehran University of Medical Sciences and the University of Arizona.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Arman Soltani Moghadam demonstrates a rare blend of clinical expertise, academic excellence, and prolific research productivity at a remarkably early career stage. With dual appointments in top-tier institutions such as Tehran Heart Center and the University of Arizona, he brings international collaboration into practice. His extensive publication record, including meta-analyses in high-impact journals like Journal of the American Heart Association, Clinical Cardiology, and Frontiers in Immunology, underlines his commitment to evidence-based cardiology. His editorial contributions to BMJ and Artificial Organs, as well as multiple conference abstracts presented at AHA and ACC, show active involvement in shaping the scientific dialogue.

Moreover, his ability to work across disciplines—ranging from echocardiography and interventional cardiology to artificial intelligence in medicine—shows a visionary mindset. His numerous certifications from Oxford, Johns Hopkins, and Coursera on clinical trials, machine learning, and statistical methods further reinforce his scientific rigour. Notably, his early leadership as a corresponding author and multiple first-author meta-analyses reflect originality and independence in research.

🎓 Education

Dr. Moghadam earned his Doctor of Medicine (M.D.) diploma from Islamic Azad University, Tehran Medical Sciences Branch (2014–2021), graduating with a commendable GPA of 3.65/4.0. Prior to that, he completed his Diploma in Natural Science at the National Organization for the Development of Exceptional Talents (NODET), where he achieved a perfect GPA of 4.0/4.0. His strong academic foundation reflects his commitment to lifelong learning and excellence in science.

💼 Experience

Currently, Dr. Moghadam works as a General Practitioner at Amiralam Hospital in Tehran, while concurrently contributing as a Research Assistant in the Department of Cardiology at Tehran University of Medical Sciences. He previously served at Chamran Hospital and completed his internship at Islamic Azad University. Additionally, he collaborates remotely with the University of Arizona as a cardiovascular research assistant, showcasing his global engagement in healthcare research.

🔬 Research Interests On Medicine

Dr. Moghadam’s research is rooted in cardiology, with focused interests in interventional cardiology, structural heart disease, electrophysiology, and echocardiography. His studies aim to bridge clinical observations with evidence-based medicine, frequently employing meta-analytical techniques and advanced statistical tools. He is passionate about improving cardiovascular outcomes through innovation and collaboration.

🏆 Awards and Honors

🏅 Ranked 1st in the Clinical Knowledge Exam among his peers, Dr. Moghadam also secured 2nd position based on GPA in his MD program. He is a recognized member of the Iranian Society of Atherosclerosis (IR SA) and actively participates in national and international scientific communities. His commitment to education is evident from his extensive teaching and mentoring experiences.

📄 Publications

  • Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
    Authors: AB Boroumand, M Forouhi, F Karimi, AS Moghadam, LG Naeini, …
    Year: 2022
    Cited by: 58

  • Human diseases Research and textbook 1: Heart, Diabetes, Bacterial, ADHD, skin
    Authors: AT Mohammadi, S Karami, A Jahandideh, S Sarejloo, S Vaseghi, …
    Year: 2022
    Cited by: 29

  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
    Authors: A Vakilpour, E Amini-Salehi, A Soltani Moghadam, MH Keivanlou, …
    Year: 2024
    Cited by: 21

  • Emerging Technologies in Medicine: Artificial Intelligence, Robotics, and Medical Automation
    Authors: M Rezaei, S Saei, SJ Khouzani, ME Rostami, M Rahmannia, …
    Year: 2023
    Cited by: 21

  • In Patients with Cardiogenic Shock, Extracorporeal Membrane Oxygenation Is Associated with Very High All-Cause Inpatient Mortality Rate
    Authors: MR Movahed, A Soltani Moghadam, M Hashemzadeh
    Year: 2024
    Cited by: 1

  • Gender-based Disparity in Performing Aortic Valve Surgery in the United State Before Availability of Percutaneous Valve Implantation
    Authors: MR Movahed, AS Moghadam, M Hashemzadeh, M Hashemzadeh
    Year: 2024
    Cited by: 1

  • Revisiting echocardiographic features of prosthetic heart valves: the necessity of correct differentiation of mono-leaflet vs. bileaflet mechanical heart valves in a case report
    Authors: SHAASM Farnoosh Larti’t, Babak Geraiely’t
    Year: 2024
    Cited by: 1

  • Intravascular Lithotripsy Versus Rotational Atherectomy in the Management of Calcific Coronary Lesions: A Systematic Review and Meta‐Analysis
    Authors: AS Moghadam, N Kakavand, FO Shirmard, A Poopak, N Anaraki, …
    Year: 2025
    Cited by: Not available

  • Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Trials
    Authors: K Tavakoli, NSH Mohammadi, P Bahiraie, S Saeidi, F Shaker, …
    Year: 2025
    Cited by: Not available

  • Time Trend Analysis of Clinical Outcomes for Drug-Coated Balloon versus Drug-Eluting Stent among Patients with Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Trials
    Authors: A Soltani Moghadam, S Kazemian, S Shojaei, Saman Soltani Moghadam, …
    Year: 2024
    Cited by: Not available

✅ Conclusion

Dr. Arman Soltani Moghadam exemplifies the fusion of clinical acumen and research innovation. With a diverse portfolio of international collaborations, high-impact publications, and a continuous pursuit of academic and clinical excellence, he stands as a strong nominee for any global medical or research award. His contributions not only enhance cardiovascular knowledge but also inspire the next generation of physician-scientists.

Tashi Negi | Health Professions | Best Researcher Award

Published on by Forensic Scientist

Dr. Tashi Negi | Health Professions | Best Researcher Award

Dr. Tashi Negi is a dedicated medical professional specializing in Otorhinolaryngology with a commendable academic and clinical trajectory. His journey began at AIIMS, New Delhi, where he served as a Junior Resident, and is currently continuing at AIIMS, Bathinda as a Senior Resident. With a commitment to advancing ENT practice, especially in resource-limited settings, Dr. Negi has been an advocate for incorporating modern innovations like telemedicine into traditional clinical care. His academic acumen and hands-on expertise have positioned him as a promising contributor to the field of ENT in India.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Clinical Relevance and Timely Research:
    Dr. Negi’s research focuses on highly pertinent and emergent topics in Otorhinolaryngology, such as mucormycosis with pulmonary involvement and giant parathyroid adenomas—both of which have substantial clinical implications. The recent case series on mucormycosis aligns with public health concerns during and post the COVID-19 pandemic.

  • Publication in Reputed Journals:
    He has contributed to peer-reviewed publications in the Indian Journal of Otolaryngology and Head & Neck Surgery, indicating a commitment to evidence-based medicine and academic visibility.

  • Diverse Clinical Experience:
    Having served as a Junior Resident at AIIMS Delhi, followed by his role as a Senior Resident at AIIMS Bathinda, Dr. Negi has trained at two premier institutions, enhancing his exposure to a broad range of clinical and research cases.

  • Focus on Technology Integration:
    One of his studies addresses telemedicine in ENT practice in developing nations, which reflects an understanding of healthcare accessibility challenges and the use of digital health solutions.

🎓 Education

Dr. Tashi Negi received his foundational medical education and specialized training in Otorhinolaryngology at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, one of India’s premier medical institutions. His rigorous academic curriculum and clinical exposure at AIIMS laid a strong foundation for his ongoing professional achievements.

💼 Experience

Dr. Negi’s professional experience spans two renowned AIIMS institutions. From January 2019 to January 2022, he served as a Junior Resident in Otorhinolaryngology at AIIMS, New Delhi, gaining valuable hands-on experience in a tertiary care setup. Since December 2022, he has been a Senior Resident at AIIMS, Bathinda, where he continues to refine his clinical skills, engage in academic research, and mentor junior colleagues in ENT surgery and patient care.

🔬 Research Interests On Health Professions

Dr. Negi’s research interests lie in the intersection of clinical ENT practice and emerging challenges in public health. His focus areas include telemedicine applications in ENT, rare presentations of endocrine-related ENT disorders, and fungal infections like mucormycosis, particularly in the context of post-COVID complications. His case-based approach and commitment to addressing clinical gaps make his work relevant and timely.

🏆 Awards

While formal awards are not explicitly listed, Dr. Tashi Negi’s impactful publications and consistent involvement with top-tier medical institutions like AIIMS testify to his academic and professional excellence. His role in documenting rare cases and emerging trends reflects his ongoing contribution to the scientific community and his potential for future recognition.

📚 Publications

  1. “Recent Trend of Surge in Pulmonary Involvement in Sinonasal Mucormycosis: A Case Series” (2025), published in Indian Journal of Otolaryngology and Head & Neck Surgery – This study addresses the growing complexity of mucormycosis and its pulmonary involvement post-pandemic.
    👉 Read here | Cited by: 4 articles

  2. “Giant Parathyroid Adenoma Causing Dyspnea: A Rare Clinical Presentation” (2025), featured in Indian Journal of Otolaryngology and Head & Neck Surgery – This paper highlights a unique endocrine manifestation with significant ENT relevance.
    👉 Read here | Cited by: 6 articles

  3. “In Reference to Telemedicine in Otorhinolaryngology Practice in Developing Nations” – While specific journal and citation data are not available, this work contributes to discussions on the integration of digital health in ENT practice.

📝 Conclusion

In summary, Dr. Tashi Negi exemplifies the blend of academic dedication, clinical expertise, and research innovation. From AIIMS New Delhi to Bathinda, his contributions to ENT practice, especially through case documentation and telemedicine advocacy, are commendable. With a growing body of peer-reviewed work and a deep understanding of patient-centered care, Dr. Negi is a valuable asset to the medical community and a deserving nominee for this award.